Armistice Capital, LLC and Steven Boyd filed Amendment No. 9 to their beneficial ownership statement with the SEC on November 16, 2026, disclosing that they no longer hold any shares of Orthofix Medical Inc. common stock as of September 30, 2026.
Key Highlights
- Zero beneficial ownership: Both Armistice Capital, LLC and Steven Boyd report 0.00% of Orthofix Medical Inc. common stock as of the September 30, 2026 event date.
- All voting and dispositive power eliminated: Sole voting power, shared voting power, sole dispositive power, and shared dispositive power are each reported as 0.00 for both reporting persons.
- Amendment No. 9: This filing is the ninth amendment to the original beneficial ownership statement by the reporting persons.
- Item 5 triggered: The filing indicates ownership of 5 percent or less of a class, consistent with the 0.00% reported figure.
- Reporting persons identified: Armistice Capital, LLC (Delaware, classified as investment adviser and other) and Steven Boyd (United States, classified as holding company and individual) filed jointly from 510 Madison Avenue, 7th Floor, New York, New York 10022.
Armistice Capital and Steven Boyd Report Full Exit from Orthofix Medical Common Stock
According to the filing, Armistice Capital, LLC serves as the investment manager of Armistice Capital Master Fund Ltd., described as the direct holder of shares in the issuer. The filing states that pursuant to an Investment Management Agreement, Armistice Capital exercises voting and investment power over the securities held by the Master Fund and thus may be deemed to beneficially own those securities. Steven Boyd, as managing member of Armistice Capital, is similarly identified as a reporting person.
The filing discloses that as of the event date of September 30, 2026, the aggregate amount beneficially owned by each reporting person is 0, representing 0.00% of the class. Orthofix Medical Inc., the issuer, is a medical device company headquartered at 3451 Plano Parkway, Lewisville, TX 75056, whose common stock carries a par value of $0.10 per share and trades under CUSIP number 68752M108 on NASDAQ:OFIX. The filing further notes that the Master Fund "specifically disclaims beneficial ownership of the securities of the Issuer directly held by it by virtue of its inability to vote or dispose of such securities as a result of its Investment Management Agreement with Armistice Capital."
The certifications included in the filing state that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer." The statement was signed by Steven Boyd in his capacity as managing member of Armistice Capital, LLC and individually, and is dated November 16, 2026.
What Was Disclosed
Armistice Capital, LLC and Steven Boyd disclosed through Amendment No. 9 that as of September 30, 2026, they beneficially own zero shares of Orthofix Medical Inc. common stock, representing 0.00% of the class, with no voting or dispositive power remaining.




Please wait processing your request...